Chi-Fu Jeffrey Yang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonectomy | 53 | 2024 | 1111 | 8.920 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 68 | 2024 | 5251 | 8.170 |
Why?
|
Lung Neoplasms | 100 | 2024 | 13262 | 7.640 |
Why?
|
Thoracic Surgery, Video-Assisted | 16 | 2022 | 277 | 4.740 |
Why?
|
Neoplasm Staging | 73 | 2024 | 11152 | 3.990 |
Why?
|
Esophageal Neoplasms | 14 | 2023 | 1648 | 2.280 |
Why?
|
Esophagectomy | 12 | 2023 | 466 | 2.270 |
Why?
|
Small Cell Lung Carcinoma | 6 | 2023 | 421 | 2.140 |
Why?
|
Propensity Score | 16 | 2022 | 1928 | 1.490 |
Why?
|
Thymoma | 2 | 2022 | 187 | 1.340 |
Why?
|
Early Detection of Cancer | 10 | 2024 | 3202 | 1.330 |
Why?
|
Thymus Neoplasms | 2 | 2022 | 274 | 1.240 |
Why?
|
Pleural Neoplasms | 7 | 2023 | 609 | 1.200 |
Why?
|
Thoracic Surgery | 4 | 2023 | 725 | 1.160 |
Why?
|
Carcinoma, Squamous Cell | 9 | 2024 | 4024 | 1.050 |
Why?
|
Adenocarcinoma | 14 | 2024 | 6315 | 1.050 |
Why?
|
Retrospective Studies | 68 | 2024 | 80372 | 1.030 |
Why?
|
Radiosurgery | 5 | 2024 | 1343 | 1.000 |
Why?
|
Neoadjuvant Therapy | 13 | 2023 | 2821 | 0.980 |
Why?
|
Survival Rate | 28 | 2024 | 12808 | 0.940 |
Why?
|
Suicide | 3 | 2023 | 1599 | 0.900 |
Why?
|
Thymectomy | 2 | 2022 | 194 | 0.840 |
Why?
|
Mesothelioma | 4 | 2022 | 807 | 0.810 |
Why?
|
Tracheal Neoplasms | 2 | 2020 | 123 | 0.800 |
Why?
|
Chemotherapy, Adjuvant | 11 | 2023 | 3529 | 0.770 |
Why?
|
Humans | 151 | 2024 | 760621 | 0.740 |
Why?
|
Carcinoma, Adenoid Cystic | 2 | 2020 | 262 | 0.710 |
Why?
|
Databases, Factual | 15 | 2023 | 8035 | 0.710 |
Why?
|
Herpes Simplex | 1 | 2022 | 478 | 0.650 |
Why?
|
Esophageal Achalasia | 1 | 2020 | 94 | 0.640 |
Why?
|
Thoracic Surgical Procedures | 3 | 2024 | 348 | 0.640 |
Why?
|
Kaplan-Meier Estimate | 12 | 2024 | 6544 | 0.630 |
Why?
|
Thoracotomy | 5 | 2022 | 363 | 0.630 |
Why?
|
Coronavirus | 1 | 2020 | 149 | 0.600 |
Why?
|
Survival Analysis | 13 | 2024 | 10182 | 0.570 |
Why?
|
Treatment Outcome | 35 | 2023 | 65017 | 0.560 |
Why?
|
Herpesvirus 1, Human | 1 | 2022 | 753 | 0.560 |
Why?
|
Aged | 59 | 2024 | 169152 | 0.560 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2016 | 30 | 0.560 |
Why?
|
Proportional Hazards Models | 14 | 2024 | 12531 | 0.550 |
Why?
|
Robotics | 2 | 2022 | 874 | 0.550 |
Why?
|
United States | 33 | 2024 | 72461 | 0.540 |
Why?
|
Middle Aged | 57 | 2024 | 220352 | 0.530 |
Why?
|
Frozen Sections | 1 | 2016 | 153 | 0.530 |
Why?
|
Thoracoscopy | 2 | 2016 | 176 | 0.510 |
Why?
|
Hospitals, General | 1 | 2020 | 795 | 0.510 |
Why?
|
Lymphatic Metastasis | 4 | 2024 | 2943 | 0.510 |
Why?
|
Parenteral Nutrition | 2 | 2011 | 656 | 0.500 |
Why?
|
Metformin | 1 | 2023 | 912 | 0.500 |
Why?
|
Male | 74 | 2024 | 359744 | 0.490 |
Why?
|
Lymph Nodes | 6 | 2023 | 3486 | 0.480 |
Why?
|
Eligibility Determination | 4 | 2024 | 421 | 0.470 |
Why?
|
Actigraphy | 1 | 2018 | 518 | 0.460 |
Why?
|
Pandemics | 7 | 2023 | 8624 | 0.450 |
Why?
|
Female | 71 | 2024 | 391270 | 0.450 |
Why?
|
Carcinoma, Small Cell | 1 | 2016 | 416 | 0.440 |
Why?
|
Time Factors | 15 | 2020 | 40165 | 0.430 |
Why?
|
Pneumothorax | 1 | 2016 | 379 | 0.430 |
Why?
|
Cranial Irradiation | 1 | 2016 | 391 | 0.430 |
Why?
|
Combined Modality Therapy | 10 | 2023 | 8552 | 0.420 |
Why?
|
Smoking | 4 | 2024 | 9073 | 0.410 |
Why?
|
Registries | 3 | 2021 | 8469 | 0.400 |
Why?
|
Cause of Death | 2 | 2019 | 3725 | 0.380 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2023 | 167 | 0.380 |
Why?
|
Puerto Rico | 5 | 2019 | 373 | 0.380 |
Why?
|
Carcinoma, Neuroendocrine | 3 | 2019 | 346 | 0.370 |
Why?
|
Intention to Treat Analysis | 3 | 2021 | 422 | 0.360 |
Why?
|
Lung Transplantation | 1 | 2020 | 1305 | 0.360 |
Why?
|
Short Bowel Syndrome | 2 | 2011 | 353 | 0.350 |
Why?
|
Tomography, X-Ray Computed | 7 | 2024 | 20509 | 0.340 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2022 | 1791 | 0.330 |
Why?
|
Secondary Prevention | 1 | 2016 | 1548 | 0.330 |
Why?
|
Antineoplastic Agents | 5 | 2019 | 13630 | 0.320 |
Why?
|
Carcinoma, Large Cell | 2 | 2019 | 113 | 0.320 |
Why?
|
Mediastinum | 2 | 2023 | 266 | 0.310 |
Why?
|
Cohort Studies | 13 | 2024 | 41335 | 0.310 |
Why?
|
Occupational Diseases | 2 | 2024 | 1486 | 0.310 |
Why?
|
Neoplasms | 3 | 2023 | 22072 | 0.300 |
Why?
|
Research | 1 | 2016 | 1974 | 0.300 |
Why?
|
Prognosis | 15 | 2024 | 29658 | 0.300 |
Why?
|
Micronutrients | 1 | 2011 | 381 | 0.300 |
Why?
|
SEER Program | 6 | 2021 | 1530 | 0.300 |
Why?
|
Enteral Nutrition | 2 | 2011 | 785 | 0.300 |
Why?
|
Postoperative Complications | 3 | 2022 | 15697 | 0.290 |
Why?
|
Education, Medical, Graduate | 1 | 2020 | 2363 | 0.290 |
Why?
|
Neoplasm Invasiveness | 4 | 2024 | 3618 | 0.290 |
Why?
|
Practice Guidelines as Topic | 3 | 2021 | 7475 | 0.280 |
Why?
|
Evidence-Based Medicine | 2 | 2015 | 3696 | 0.270 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2011 | 368 | 0.270 |
Why?
|
Alanine Transaminase | 1 | 2009 | 606 | 0.270 |
Why?
|
Follow-Up Studies | 12 | 2020 | 39261 | 0.270 |
Why?
|
Behavior | 1 | 2009 | 540 | 0.260 |
Why?
|
Fingers | 1 | 2009 | 506 | 0.260 |
Why?
|
Intra-Aortic Balloon Pumping | 3 | 2012 | 227 | 0.260 |
Why?
|
Tumor Burden | 2 | 2020 | 1895 | 0.250 |
Why?
|
Lymph Node Excision | 2 | 2023 | 1303 | 0.250 |
Why?
|
Neoplasms, Second Primary | 1 | 2023 | 1056 | 0.250 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1677 | 0.250 |
Why?
|
Men | 1 | 2005 | 64 | 0.240 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6828 | 0.240 |
Why?
|
Patient Selection | 2 | 2016 | 4283 | 0.230 |
Why?
|
Liver Diseases | 2 | 2010 | 1302 | 0.230 |
Why?
|
Lung | 6 | 2024 | 9994 | 0.230 |
Why?
|
Mental Disorders | 1 | 2023 | 6796 | 0.220 |
Why?
|
Space Perception | 1 | 2006 | 464 | 0.220 |
Why?
|
Brain Neoplasms | 2 | 2023 | 8986 | 0.210 |
Why?
|
Fomites | 1 | 2022 | 15 | 0.210 |
Why?
|
Postoperative Period | 2 | 2019 | 1818 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2021 | 10344 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.200 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2018 | 3602 | 0.200 |
Why?
|
Biopsy | 4 | 2019 | 6771 | 0.200 |
Why?
|
Testosterone | 3 | 2009 | 2470 | 0.200 |
Why?
|
Counterpulsation | 2 | 2012 | 18 | 0.200 |
Why?
|
Vero Cells | 1 | 2022 | 482 | 0.190 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2023 | 97 | 0.190 |
Why?
|
Sarcoma | 1 | 2022 | 1786 | 0.190 |
Why?
|
Botulinum Toxins | 1 | 2023 | 188 | 0.190 |
Why?
|
Cross-Cultural Comparison | 1 | 2005 | 633 | 0.190 |
Why?
|
Pericardial Effusion | 1 | 2023 | 247 | 0.190 |
Why?
|
Radiation | 1 | 2020 | 48 | 0.190 |
Why?
|
Pattern Recognition, Visual | 1 | 2006 | 810 | 0.180 |
Why?
|
Peristalsis | 1 | 2020 | 59 | 0.180 |
Why?
|
Esophagus | 4 | 2020 | 1023 | 0.170 |
Why?
|
Body Image | 1 | 2005 | 635 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9276 | 0.170 |
Why?
|
Internship and Residency | 1 | 2020 | 5870 | 0.170 |
Why?
|
Risk Factors | 10 | 2023 | 74359 | 0.170 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11712 | 0.160 |
Why?
|
Italy | 1 | 2021 | 841 | 0.160 |
Why?
|
Ontario | 1 | 2020 | 404 | 0.160 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2019 | 88 | 0.160 |
Why?
|
North Carolina | 2 | 2020 | 325 | 0.160 |
Why?
|
Aged, 80 and over | 8 | 2022 | 58995 | 0.160 |
Why?
|
Viruses | 1 | 2022 | 376 | 0.160 |
Why?
|
Sex Characteristics | 1 | 2009 | 2629 | 0.150 |
Why?
|
Oxidation-Reduction | 1 | 2024 | 2222 | 0.150 |
Why?
|
Patient Discharge | 1 | 2021 | 3476 | 0.150 |
Why?
|
Musculoskeletal Diseases | 2 | 2024 | 595 | 0.150 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3388 | 0.150 |
Why?
|
Esophagoscopy | 1 | 2019 | 390 | 0.150 |
Why?
|
Canada | 1 | 2023 | 2128 | 0.150 |
Why?
|
Cytoskeleton | 1 | 2022 | 1167 | 0.150 |
Why?
|
Occupational Health | 2 | 2024 | 805 | 0.140 |
Why?
|
Population Surveillance | 2 | 2019 | 2608 | 0.140 |
Why?
|
Nomograms | 1 | 2019 | 238 | 0.140 |
Why?
|
Adult | 14 | 2023 | 219994 | 0.140 |
Why?
|
Advisory Committees | 1 | 2021 | 788 | 0.140 |
Why?
|
Happiness | 1 | 2018 | 170 | 0.140 |
Why?
|
Sarcopenia | 1 | 2021 | 372 | 0.130 |
Why?
|
Antioxidants | 1 | 2024 | 1667 | 0.130 |
Why?
|
Chest Tubes | 1 | 2016 | 152 | 0.130 |
Why?
|
Feasibility Studies | 3 | 2022 | 5201 | 0.130 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2016 | 260 | 0.130 |
Why?
|
Health Services Needs and Demand | 1 | 2023 | 1399 | 0.130 |
Why?
|
China | 2 | 2020 | 2339 | 0.130 |
Why?
|
Outpatients | 1 | 2023 | 1607 | 0.120 |
Why?
|
Virus Replication | 1 | 2022 | 2432 | 0.120 |
Why?
|
Immunotherapy | 5 | 2023 | 4642 | 0.120 |
Why?
|
Mastectomy, Segmental | 1 | 2019 | 972 | 0.120 |
Why?
|
Frail Elderly | 1 | 2019 | 752 | 0.120 |
Why?
|
Length of Stay | 3 | 2021 | 6479 | 0.110 |
Why?
|
Professional Practice | 1 | 2015 | 313 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2895 | 0.110 |
Why?
|
Risk Assessment | 3 | 2019 | 24123 | 0.110 |
Why?
|
Genes, ras | 1 | 2016 | 655 | 0.110 |
Why?
|
Perioperative Care | 2 | 2024 | 1037 | 0.110 |
Why?
|
Antiviral Agents | 2 | 2022 | 3061 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3306 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2022 | 1231 | 0.110 |
Why?
|
Alcoholism | 1 | 2023 | 1961 | 0.110 |
Why?
|
Caregivers | 1 | 2024 | 2224 | 0.100 |
Why?
|
Wavelet Analysis | 1 | 2012 | 55 | 0.100 |
Why?
|
Geriatric Assessment | 1 | 2019 | 1405 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12159 | 0.100 |
Why?
|
Patient Readmission | 2 | 2021 | 3323 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 650 | 0.100 |
Why?
|
Incidence | 2 | 2023 | 21392 | 0.090 |
Why?
|
Recurrence | 1 | 2023 | 8482 | 0.090 |
Why?
|
Data Mining | 1 | 2015 | 553 | 0.090 |
Why?
|
Saliva | 2 | 2022 | 820 | 0.090 |
Why?
|
Pneumonia | 1 | 2022 | 2131 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2852 | 0.090 |
Why?
|
Carbon Isotopes | 1 | 2010 | 459 | 0.080 |
Why?
|
Breath Tests | 1 | 2010 | 297 | 0.080 |
Why?
|
Logistic Models | 3 | 2018 | 13314 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5253 | 0.080 |
Why?
|
RNA, Messenger | 1 | 2024 | 12766 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1864 | 0.080 |
Why?
|
Liver Function Tests | 1 | 2010 | 524 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2543 | 0.080 |
Why?
|
Methionine | 1 | 2010 | 569 | 0.080 |
Why?
|
Sepsis | 1 | 2022 | 2592 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5787 | 0.070 |
Why?
|
Odds Ratio | 2 | 2020 | 9716 | 0.070 |
Why?
|
Mass Screening | 3 | 2024 | 5423 | 0.070 |
Why?
|
Cisplatin | 2 | 2024 | 1644 | 0.070 |
Why?
|
Carbon Dioxide | 1 | 2010 | 1146 | 0.070 |
Why?
|
Intestinal Diseases | 1 | 2010 | 506 | 0.060 |
Why?
|
Quality of Life | 2 | 2024 | 13308 | 0.060 |
Why?
|
Models, Cardiovascular | 1 | 2011 | 978 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25942 | 0.060 |
Why?
|
Somatotypes | 1 | 2005 | 41 | 0.060 |
Why?
|
Coronary Circulation | 1 | 2011 | 1577 | 0.060 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 1097 | 0.060 |
Why?
|
Salivary Glands | 1 | 2006 | 229 | 0.060 |
Why?
|
Body Height | 1 | 2011 | 1570 | 0.060 |
Why?
|
Psychological Tests | 1 | 2006 | 639 | 0.060 |
Why?
|
Anthropometry | 1 | 2009 | 1348 | 0.060 |
Why?
|
Laparoscopy | 1 | 2016 | 2147 | 0.060 |
Why?
|
Hemodynamics | 2 | 2011 | 4174 | 0.060 |
Why?
|
Taiwan | 1 | 2005 | 505 | 0.060 |
Why?
|
Age Factors | 2 | 2019 | 18416 | 0.050 |
Why?
|
Forecasting | 1 | 2012 | 2932 | 0.050 |
Why?
|
Hospitalization | 1 | 2023 | 10790 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8950 | 0.050 |
Why?
|
Fathers | 1 | 2006 | 376 | 0.050 |
Why?
|
5' Untranslated Regions | 1 | 2024 | 256 | 0.050 |
Why?
|
Medicare | 1 | 2021 | 6786 | 0.050 |
Why?
|
Vitamins | 1 | 2011 | 1634 | 0.050 |
Why?
|
Anabolic Agents | 1 | 2005 | 253 | 0.050 |
Why?
|
Sleep | 1 | 2018 | 4751 | 0.050 |
Why?
|
Pleura | 1 | 2023 | 244 | 0.050 |
Why?
|
Somatoform Disorders | 1 | 2005 | 423 | 0.050 |
Why?
|
Telephone | 1 | 2024 | 624 | 0.050 |
Why?
|
Animals | 7 | 2024 | 167963 | 0.050 |
Why?
|
Personal Satisfaction | 1 | 2005 | 643 | 0.040 |
Why?
|
Body Weight | 1 | 2011 | 4611 | 0.040 |
Why?
|
Heart-Assist Devices | 1 | 2011 | 1291 | 0.040 |
Why?
|
Sex Factors | 1 | 2023 | 10547 | 0.040 |
Why?
|
State Medicine | 1 | 2021 | 213 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2023 | 3865 | 0.040 |
Why?
|
Gender Identity | 1 | 2005 | 698 | 0.040 |
Why?
|
Swine, Miniature | 2 | 2012 | 959 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 555 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2023 | 3986 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2024 | 910 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2023 | 604 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3620 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11345 | 0.040 |
Why?
|
Europe | 1 | 2005 | 3441 | 0.040 |
Why?
|
Young Adult | 2 | 2018 | 58741 | 0.040 |
Why?
|
Prevalence | 1 | 2023 | 15687 | 0.030 |
Why?
|
Remission Induction | 1 | 2021 | 2392 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2021 | 843 | 0.030 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2015 | 94 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2024 | 1894 | 0.030 |
Why?
|
Liver | 1 | 2010 | 7509 | 0.030 |
Why?
|
Heparin | 1 | 2022 | 1652 | 0.030 |
Why?
|
Trachea | 1 | 2020 | 1082 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14495 | 0.030 |
Why?
|
Models, Animal | 2 | 2011 | 2117 | 0.030 |
Why?
|
Linear Models | 1 | 2024 | 5877 | 0.030 |
Why?
|
Suicidal Ideation | 1 | 2023 | 1425 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 3113 | 0.030 |
Why?
|
Nitric Oxide Synthase | 1 | 2016 | 908 | 0.030 |
Why?
|
Carboplatin | 1 | 2016 | 788 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2024 | 3446 | 0.030 |
Why?
|
Coronary-Subclavian Steal Syndrome | 1 | 2012 | 2 | 0.030 |
Why?
|
Swine | 2 | 2012 | 5899 | 0.020 |
Why?
|
Endoscopy | 1 | 2020 | 1838 | 0.020 |
Why?
|
Infant | 2 | 2010 | 36060 | 0.020 |
Why?
|
Child, Preschool | 2 | 2011 | 42063 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9467 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 174 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2015 | 1809 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 2011 | 321 | 0.020 |
Why?
|
Mitochondria, Liver | 1 | 2010 | 190 | 0.020 |
Why?
|
Heterozygote | 1 | 2016 | 2798 | 0.020 |
Why?
|
Sus scrofa | 1 | 2011 | 433 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10551 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3213 | 0.020 |
Why?
|
Hospitals | 1 | 2022 | 3928 | 0.020 |
Why?
|
Systole | 1 | 2011 | 947 | 0.020 |
Why?
|
Diastole | 1 | 2011 | 788 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4371 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2010 | 1385 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8515 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 16939 | 0.020 |
Why?
|
Social Class | 1 | 2016 | 2005 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15289 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5643 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4897 | 0.020 |
Why?
|
Brain | 1 | 2023 | 26951 | 0.020 |
Why?
|
Paternal Behavior | 1 | 2006 | 33 | 0.020 |
Why?
|
Software | 1 | 2020 | 4419 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13502 | 0.020 |
Why?
|
Prospective Studies | 1 | 2020 | 54303 | 0.020 |
Why?
|
Mutation | 2 | 2023 | 29932 | 0.020 |
Why?
|
Alleles | 1 | 2016 | 6898 | 0.020 |
Why?
|
Depression | 1 | 2023 | 8044 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2011 | 2135 | 0.010 |
Why?
|
Mice | 2 | 2024 | 81208 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2010 | 2192 | 0.010 |
Why?
|
Child | 1 | 2011 | 79806 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9501 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2012 | 2696 | 0.010 |
Why?
|
Electrocardiography | 1 | 2012 | 6414 | 0.010 |
Why?
|
Stroke Volume | 1 | 2012 | 5523 | 0.010 |
Why?
|
Boston | 1 | 2010 | 9280 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18137 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8525 | 0.010 |
Why?
|
Algorithms | 1 | 2012 | 13981 | 0.010 |
Why?
|